Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
Kidney Int
    March 2023
  1. OLIVARI V, Di Modica SM, Lidonnici MR, Aghajan M, et al
    A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease.
    Kidney Int. 2023 Mar 27:S0085-2538(23)00179-5. doi: 10.1016/j.kint.2023.
    >> Share

    November 2022
  2. KETTRITZ R, Duttmann W, Brand A, Luft FC, et al
    The Case | Is this hemolytic uremic syndrome?
    Kidney Int. 2022;102:1195-1196.
    >> Share

    August 2022
  3. FUCHS MAA, Kurtz A
    The fate of erythropoietin-producing cells: another piece of the puzzle.
    Kidney Int. 2022;102:230-233.
    >> Share

    June 2022
  4. BATTE A, Menon S, Ssenkusu JM, Kiguli S, et al
    Neutrophil gelatinase-associated lipocalin is elevated in children with acute kidney injury and sickle cell anemia, and predicts mortality.
    Kidney Int. 2022 Jun 16. pii: S0085-2538(22)00453.
    >> Share

  5. VAN DEN BROEK B, van der Flier M, van de Kar NCAJ, Wetzels JFM, et al
    Eculizumab impairs killing of Neisseria meningitidis serogroup B in atypical hemolytic uremic syndrome patients vaccinated with MenB-4C.
    Kidney Int. 2022;101:1293-1295.
    >> Share

  6. WAGENER FADTG, van de Kar NCAJ, van den Heuvel LP
    Protective mechanisms harnessing against injurious heme and preventing kidney damage in STEC-HUS: toward new therapies?
    Kidney Int. 2022;101:1107-1109.
    >> Share

  7. PIRSCHEL W, Mestekemper AN, Wissuwa B, Krieg N, et al
    Divergent roles of haptoglobin and hemopexin deficiency for disease progression of Shiga-toxin-induced hemolytic-uremic syndrome in mice.
    Kidney Int. 2022;101:1171-1185.
    >> Share

    May 2022
  8. KANEKO K, Sato Y, Uchino E, Toriu N, et al
    Lineage tracing analysis defines erythropoietin-producing cells as a distinct subpopulation of resident fibroblasts with unique behaviors.
    Kidney Int. 2022 May 26. pii: S0085-2538(22)00376.
    >> Share

  9. LABES R, Brinkmann L, Kulow VA, Roegner K, et al
    Daprodustat prevents Cyclosporine-A mediated anemia and peritubular capillary loss.
    Kidney Int. 2022 May 25. pii: S0085-2538(22)00375.
    >> Share

    April 2022
  10. HANUDEL MR, Czaya B, Wong S, Rappaport M, et al
    Enteral ferric citrate absorption is dependent on the iron transport protein ferroportin.
    Kidney Int. 2022;101:711-719.
    >> Share

  11. HAASE VH
    The ins and outs of ferric citrate.
    Kidney Int. 2022;101:668-670.
    >> Share

    March 2022
  12. JOLES JA
    Anemia and red blood cell deformability in proteinuric chronic kidney disease.
    Kidney Int. 2022;101:649.
    >> Share

    December 2021
  13. DRUEKE TB, Massy ZA
    Role of proteinuria in the anemia of chronic kidney disease.
    Kidney Int. 2021;100:1160-1162.
    >> Share

    September 2021
  14. BISSINGER R, Nemkov T, D Alessandro A, Grau M, et al
    Proteinuric chronic kidney disease is associated with altered red blood cell lifespan, deformability and metabolism.
    Kidney Int. 2021 Sep 16. pii: S0085-2538(21)00858.
    >> Share

    August 2021
  15. LILL JK, Thiebes S, Pohl JM, Bottek J, et al
    Tissue-resident macrophages mediate neutrophil recruitment and kidney injury in shiga toxin-induced hemolytic uremic syndrome.
    Kidney Int. 2021;100:349-363.
    >> Share

  16. BOUWMEESTER RN, van de Kar NCAJ, Wetzels JFM
    Enough is enough: targeted eculizumab withdrawal in atypical hemolytic uremic syndrome.
    Kidney Int. 2021;100:265-268.
    >> Share

    July 2021
  17. SCIESIELSKI LK, Felten M, Michalick L, Kirschner KM, et al
    The circadian clock regulates rhythmic erythropoietin expression in the murine kidney.
    Kidney Int. 2021 Jul 29. pii: S0085-2538(21)00729.
    >> Share

  18. IKEDA Y
    Novel roles of HIF-PHIs in chronic kidney disease: the link between iron metabolism, kidney function, and FGF23.
    Kidney Int. 2021;100:14-16.
    >> Share

  19. ARICETA G, Dixon BP, Kim SH, Kapur G, et al
    The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naive to complement inhibitor treatment.
    Kidney Int. 2021;100:225-237.
    >> Share

    June 2021
  20. KOYUN M, Kaya Aksoy G, Comak E, Ozaltin F, et al
    Outcome of diacylglycerol kinase epsilon-mediated hemolytic uremic syndrome in an infant.
    Kidney Int. 2021;99:1500-1501.
    >> Share

    April 2021
  21. BABITT JL, Eisenga MF, Haase VH, Kshirsagar AV, et al
    Controversies in Optimal Anemia Management: Conclusions from a Kidney Disease Improving Global Outcomes (KDIGO) Conference.
    Kidney Int. 2021 Apr 8. pii: S0085-2538(21)00355.
    >> Share

    March 2021
  22. HANUDEL MR, Wong S, Jung G, Qiao B, et al
    Amelioration of chronic kidney disease-associated anemia by vadadustat in mice is not dependent on erythroferrone.
    Kidney Int. 2021 Mar 31. pii: S0085-2538(21)00354.
    >> Share

  23. FUCHS MAA, Broeker KAE, Schrankl J, Burzlaff N, et al
    Inhibition of transforming growth factor beta1 signaling in resident interstitial cells attenuates profibrotic gene expression and preserves erythropoietin production during experimental kidney fibrosis in mice.
    Kidney Int. 2021 Mar 8. pii: S0085-2538(21)00278.
    >> Share

    January 2021
  24. VILLE S, Le Bot S, Chapelet-Debout A, Blancho G, et al
    Atypical HUS relapse triggered by COVID-19.
    Kidney Int. 2021;99:267-268.
    >> Share

    November 2020
  25. NORIS M, Remuzzi G
    Atypical hemolytic uremic syndrome associated with a factor B genetic variant and fluid-phase complement activation: an exception to the rule?
    Kidney Int. 2020;98:1084-1087.
    >> Share

  26. HASSANEIN M, Liaqat A, Paratore DA, Vachharajani TJ, et al
    The Case | Arrhythmias in a patient with sickle cell disease on hemodialysis.
    Kidney Int. 2020;98:1357-1358.
    >> Share

    May 2019
  27. CAVERO T, Arjona E, Soto K, Caravaca-Fontan F, et al
    Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome.
    Kidney Int. 2019 May 31. pii: S0085-2538(19)30582.
    >> Share

  28. CHO ME, Hansen JL, Peters CB, Cheung AK, et al
    An increased mortality risk is associated with abnormal iron status in diabetic and non-diabetic Veterans with predialysis chronic kidney disease.
    Kidney Int. 2019 May 15. pii: S0085-2538(19)30506.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016